DR4 antibodies and uses thereof

Details for Australian Patent Application No. 2005201915 (hide)

Owner Genentech, Inc.

Inventors Dodge, Kelly H; Ashkenazi, Avi J; Kim, Kyung Jin; Chuntharapai, Anan

Agent Griffith Hack

Pub. Number AU-B-2005201915

Parent 52967

Filing date 5 May 2005

Wipo publication date 2 June 2005

Acceptance publication date 22 January 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

19 May 2005 Complete Application Filed

2 June 2005 Application Open to Public Inspection

  Published as AU-B-2005201915

22 January 2009 Application Accepted

  Published as AU-B-2005201915

21 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201916-G protein-coupled receptor upregulated in prostate cancer and uses thereof

2005201914-Method and apparatus for setting power for transmitting signaling information on an E-DCH